Diabetes Series Live

Online Events

Basal Insulins

  • CME
    1.0

    The Evolution of Basal Insulins: One Small Step or a Giant Leap?

    Speakers:Alissa Segal, PharmD, CDE, CDTC, FCCP, Associate Professor of Pharmacy Practice
    Richard Beaser, MD, Associate Professor of Medicine
    Richard Pratley, MD, Medical Director

    Duration: 60 minutes

    Presented on: October 13, 2016

Medication Advancement

  • CME
    1.0

    The Evolving Spectrum of Antidiabetes Medications: Practical Perspectives and Clinical Challenges

    Speakers:Richard Beaser, MD, Associate Professor of Medicine
    Mark E. Molitch, MD, Professor in Medicine-Endocrinology
    Martin J. Abrahamson, MD, Associate Professor of Medicine

    Duration: 60 minutes

    Presented on: October 6, 2016

SGLT-2

  • CME
    1.0

    SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes: Methodology and Monitoring Impact

    Speakers:Richard Beaser, MD, Associate Professor of Medicine
    Nuha El Sayed, MD, Director - International Training Programs

    Duration: 60 minutes

    Presented on: August 10, 2016

Emerging Insulins

  • CME
    1.0

    Evolving Insulin Options in Type 1 and Type 2 Diabetes

    Speakers:Richard Beaser, MD, Associate Professor of Medicine
    Priscilla Hollander, MD, PhD, Endocrinologist
    Larry Blonde, MD, Director, Ochsner Diabetes Clinical Research Unit

    Duration: 60 minutes

    Presented on: June 14, 2016

  • CME
    1.0

    Leveraging New Insulin Options to Achieve Goals and Ensure Safety

    Speakers:Anne Peters, MD, CDE, Professor of Medicine
    Alissa Segal, PharmD, CDE, CDTC, FCCP, Associate Professor of Pharmacy Practice
    Richard Beaser, MD, Associate Professor of Medicine

    Duration: 60 minutes

    Presented on: June 14, 2016

  • CME
    1.0

    Case-Based Clinical Application of the New Insulins

    Speakers:Mark Stolar, MD, Associate Professor of Clinical Medicine
    Richard Beaser, MD, Associate Professor of Medicine
    Eugene Wright, MD, Medical Director, Primary Care and Specialty Practices

    Duration: 60 minutes

    Presented on: August 4, 2016

  • CME
    1.0

    Expert Opinion on Diabetes Management with New Insulins

    Speakers:Jason Gaglia, MD, Assistant Professor of Medicine
    Richard Beaser, MD, Associate Professor of Medicine
    Peter N. Weissman, MD, FACP, FACE, Associate Clinical Professor of Medicine

    Duration: 60 minutes

    Presented on: August 4, 2016

Speakers

Basal Insulins

  • Alissa Segal, PharmD, CDE, CDTC, FCCP

    Alissa Segal, PharmD, CDE, CDTC, FCCP

    Alissa Segal, PharmD, CDE, CDTC, FCCP

    Associate Professor of Pharmacy Practice

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Associate Professor of Medicine

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Richard Pratley, MD

    Richard Pratley, MD

    Richard Pratley, MD

    Medical Director

    Richard E. Pratley, MD, is Medical Director, Education and Research at the Florida Hospital Diabetes Institute, Senior Investigator at the Translational Research Institute for Metabolism and Diabetes, and an adjunct professor at the Sanford Burnham Prebys Medical Discovery Institute at Lake Nona in Orlando. Dr Pratley’s research interests include the prevention of diabetes, improving the care for older persons with diabetes, developing new drugs to treat and prevent diabetes and its complications, and understanding the role of the fat cell in increasing the risk of diabetes and heart disease. He has written several peer-reviewed articles, is a principal investigator for various trials in diabetes and obesity, and is an editorial board member and ad hoc reviewer for various journals.

Medication Advancement

  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Associate Professor of Medicine

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Mark E. Molitch, MD

    Mark E. Molitch, MD

    Mark E. Molitch, MD

    Professor in Medicine-Endocrinology

    Mark Molitch, M.D. is the Martha Leland Sherwin Professor of Medicine in the Division of Endocrinology, Metabolism and Molecular Medicine at the Northwestern University Feinberg School of Medicine. Prior to coming to Northwestern in 1984, Dr. Molitch was an Associate Professor at Tufts University School of Medicine in Boston, Massachusetts. Dr. Molitch has participated in clinical research for many years, focusing on diabetic kidney disease and other long-term complications of diabetes. He has been the PI for the Northwestern center of the Diabetes Control and Complications Trial (DCCT) and its follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC) study, the Northwestern Center of the ongoing Diabetes Prevention Program Observational Study (DPPOS), the Northwestern center of the ongoing Prevention of Early Renal Loss (PERL) study in patients with type 1 diabetes, and was the Co-Principal Investigator for Northwestern center of Diabetes of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D). He has also had a long-standing interest in the pathogenesis and treatment of pituitary tumors. Dr. Molitch has been active in the American Diabetes Association (ADA). He chaired the Professional Practice Committee that wrote the 2002 ADA”Standards of Medical Care for Patients with Diabetes Mellitus,” chaired the working group that wrote the ADA Position Statement “Diabetic Nephropathy,” and served as chair of the ADA’s Provider Recognition Program. He also chaired the Technical Expert Review Panel of the National Diabetes Quality Improvement Alliance. In addition to editing eight books and journal volumes, Dr. Molitch has authored or coauthored more than 450 original papers, review articles, book chapters, case reports and other publications. In 1997, Dr. Molitch was the recipient of the “Outstanding Physician Educator in the Field of Diabetes Award” by the American Diabetes Association and in 2013 was the recipient of the “Distinguished Educator Award” of The Endocrine Society. In 2006 he was elected to the Council of The Endocrine Society. He also completed a 3 year term as Chair of the Clinical Endocrinology Update Program of the Endocrine Society in 2012 and was President of the Pituitary Society in 2012-2013.
  • Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Associate Professor of Medicine

    Dr. Abrahamson is Associate Professor of Medicine at Harvard Medical School and Medical Director at the Joslin Diabetes Center in Boston, Massachusetts. He co-directs the Joslin – Beth Israel Deaconess Medical Center (BIDMC) Diabetes-Heart Program, a joint venture between Joslin Clinic and the Division of Cardiology at BIDMC. At Beth Israel Deaconess Medical Center, Dr. Abrahamson also serves as Director of the Division of Continuing Medical Education in the Department of Medicine. At Joslin Clinic, Dr. Abrahamson is credited with reorganizing the Adult Diabetes Section into multidisciplinary teams comprised of physicians, nurse practitioners, nurse educators, nutritionists, and exercise physiologists. He is spearheading “pathways of care” for patients referred to Joslin (JoslinCare), has co-authored guidelines for both the pharmacological and perioperative management of patients with diabetes and management of hyperglycemic emergencies, and has authored more than 50 papers, review articles and chapters related to diabetes. He received his medical degree from University of Cape Town in Cape Town, South Africa, and completed his internship and residency in internal medicine and endocrinology at Groote Schuur Hospital, also in Cape Town, where he was a research fellow before joining the faculty of medicine at the University of Cape Town and Groote Schuur Hospital. Dr. Abrahamson was joint head of the endocrine unit in Cape Town before taking up a faculty appointment at Harvard Medical School and Beth Israel Hospital in 1992. Dr. Abrahamson’s research interests include evaluation of the efficacy and utility of a continuous glucose monitoring sensors in the management of patients with diabetes, and prevalence of silent coronary ischemia in patients with diabetes. Dr. Abrahamson is board certified in internal medicine and in endocrinology, diabetes and metabolism, and is a Fellow of the College of Physicians of South Africa.

SGLT-2

  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Associate Professor of Medicine

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Nuha El Sayed, MD

    Nuha El Sayed, MD

    Nuha El Sayed, MD

    Director - International Training Programs

    Nuha El Sayed, MD, is the director of International Training Programs at the Joslin Diabetes Center, associate director of the Harvard Medical Faculty Physicians’ International Initiatives, a staff physician at the Joslin Diabetes Center, and instructor in medicine at Harvard Medical School. At the Joslin Diabetes Center, Dr El Sayed oversees the education and training of international fellows, residents, medical students and visitors. She specializes in caring for overweight and obese type 2 diabetes patients, and also focuses on the use of technology in types 1 and 2 diabetes. Her research focuses on short- and long-term effects of lifestyle modification, the use of technology in diabetes and lifestyle modification, new insulin formulations and cross cultural medical care.

Emerging Insulins

  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Associate Professor of Medicine

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Priscilla Hollander, MD, PhD

    Priscilla Hollander, MD, PhD

    Priscilla Hollander, MD, PhD

    Endocrinologist

    Dr. Priscilla Hollander is an endocrinologist at Baylor University Medical Center in Dallas, Texas. She graduated from Harvard medical School and also has as PhD in physiology from Yale University. She is actively involved in patient care, but also participates actively in clinical research in diabetes and obesity. She has an interest in obesity with particular attention to studying new treatments for obesity both in patients with diabetes and without diabetes. She has been very active in investigating the development and role of new insulins in both type 1 and type 2 diabetes. Dr. Hollander has published extensively in both areas. Dr. Hollander is chairman of the professional advisory committee to the Texas Diabetes Council and is also diabetes champion for the Baylor hospital system and its associated physician network. She has been active in the ADA, AACE, and the Obesity Society.
  • Larry Blonde, MD

    Larry Blonde, MD

    Larry Blonde, MD

    Director, Ochsner Diabetes Clinical Research Unit

    Lawrence Blonde, MD, FACP, MACE, is Director of the Ochsner Diabetes Clinical Research Unit in the Frank Riddick Diabetes Institute, Department of Endocrinology, at the Ochsner Medical Center in New Orleans. His clinical and research activities have focused on patients with diabetes mellitus and investigations of new therapies and health care delivery systems for them. Dr Blonde is a former Chair of the Ochsner Department of Endocrinology, served as Associate Director of Graduate Medical Education, Associate Program Director of the Internal Medicine Residency, and Program Director of the Ochsner Clinic Foundation’s Endocrinology Fellowship. He is a co-author of the 2016 AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm and is presently an associate editor for Diabetes Care.
  • Anne Peters, MD, CDE

    Anne Peters, MD, CDE

    Anne Peters, MD, CDE

    Professor of Medicine

    Anne L. Peters, MD, is currently a professor at the Keck School of Medicine of the University of Southern California and the Director of the USC Clinical Diabetes Programs. She runs two diabetes centers, one in Beverly Hills and one in underserved East Los Angeles. Dr. Peters has been a principal investigator on multiple clinical trials focusing on diabetes and diabetes prevention. She has received multiple NIH and foundation grants. She has been an invited speaker at over 300 national and international medical conferences. Dr. Peters has authored three books on diabetes and over 100 articles appearing in multiple peer-reviewed medical journals. She has served on the ABIM Endocrine Board and the Board of the ADA. Dr. Peters received the ADA Outstanding Physician Clinician Award in 2008.
  • Alissa Segal, PharmD, CDE, CDTC, FCCP

    Alissa Segal, PharmD, CDE, CDTC, FCCP

    Alissa Segal, PharmD, CDE, CDTC, FCCP

    Associate Professor of Pharmacy Practice

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Mark Stolar, MD

    Mark Stolar, MD

    Mark Stolar, MD

    Associate Professor of Clinical Medicine

    Mark Stolar, MD, is associate professor of clinical medicine, general internal medicine, and geriatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois. Dr Stolar received his medical degree from the University of Illinois, Chicago. He completed his fellowship in Endocrinology at the Northwestern University Medical School and his residency in internal medicine at Lutheran General Hospital. Dr Stolar is board certified in endocrinology, diabetes, and metabolism, and internal medicine. Dr Stolar’s academic interests include diabetes, lipid disorders, and thyroid disease. A highly regarded speaker, he is actively involved in physician education in the area of diabetes and CV disease and has both written and presented in the US and internationally in those areas. He is currently president of the Endocrine Fellows Foundation and is actively involved in enhancing career opportunities for trainees in Endocrinology.
  • Eugene Wright, MD

    Eugene Wright, MD

    Eugene Wright, MD

    Medical Director, Primary Care and Specialty Practices

    Eugene Wright, Jr., MD, is Medical Director for Primary Care and Specialty Practices, Cape Fear Valley Health System in Fayetteville, North Carolina. He holds appointments as a consulting associate in the Department of Community and Family Medicine and the Department of Medicine of Duke University Medical Center, and as a clinical associate professor at the Campbell University School of Osteopathic Medicine (CUSOM). Dr Wright practices at The Care Clinic, a clinic for underserved and uninsured patients run by Catholic charities and local community philanthropic efforts. He has served on several advisory boards and editorial boards, was a steering committee member of the Insulin Congress, and has served on the planning committee of the Clinical Conference of the ADA since 2009.
  • Jason Gaglia, MD

    Jason Gaglia, MD

    Jason Gaglia, MD

    Assistant Professor of Medicine

    Jason Gaglia, MD, MMSc is Director of the Hood Center for Prevention of Childhood Diabetes at Joslin Diabetes Center and an Assistant Professor of Medicine at Harvard Medical School. He is a practicing adult endocrinologist at Joslin Clinic and Harvard Vanguard Medical Associates. Dr. Gaglia’s research interests include endocrine imaging and immunology of diabetes. He was previously a member of the clinical islet transplant team at the National Institute of Health. More recently he has led a team demonstrating noninvasive imaging of inflammation in the pancreas associated with the development of type 1 diabetes. Dr. Gaglia is an active member of the American Association of Clinical Endocrinologists (AACE). He is on the editorial board of Endocrine Practice, the official journal of AACE, and serves on several AACE committees.
  • Peter N. Weissman, MD, FACP, FACE

    Peter N. Weissman, MD, FACP, FACE

    Peter N. Weissman, MD, FACP, FACE

    Associate Clinical Professor of Medicine

    Peter Weissman is a board-certified specialist in internal medicine, endocrinology and metabolism. Dr. Weissman is an Associate Clinical Professor of endocrinology and internal medicine at the University of Miami Miller School of Medicine in Miami, Florida, former Adjunct Director of continuing medical education at the Joslin Diabetes Center in Boston, Massachusetts, Medical Director of the Metabolic Center for osteoporosis and diabetes complications testing and is a Clinical Endocrinologist in Miami, Florida. Dr. Weissman received his medical degree from New York University School of Medicine and completed his internship and residency at Barnes Hospital, a part of Washington University School of Medicine in St. Louis. He subsequently completed a fellowship in endocrinology at the Nation Institutes of Health (NIH) in the Human Metabolism and Endocrinology Section of the Gerontology Research Center in Baltimore, Maryland. He also completed an NIH-sponsored fellowship in endocrinology at the University of Michigan in Ann Arbor, Michigan. Active in clinical research and the principal investigator for over 250 clinical trials, Dr. Weissman’s main interests involve diabetes treatment, early detection and diagnosis of diabetes complications, integrated treatment of coexistent risk factors aimed at prevention of cardiovascular disease, and osteoporosis. Dr. Weissman is a member of several professional medical associations including the American Diabetes Association, the Endocrine Society, the American Association of Clinical Endocrinologists and the American Society for Bone and Mineral Research.

All Speakers

  • Alissa Segal, PharmD, CDE, CDTC, FCCP

    Alissa Segal, PharmD, CDE, CDTC, FCCP

    Alissa Segal, PharmD, CDE, CDTC, FCCP

    Associate Professor of Pharmacy Practice

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Associate Professor of Medicine

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Richard Pratley, MD

    Richard Pratley, MD

    Richard Pratley, MD

    Medical Director

    Richard E. Pratley, MD, is Medical Director, Education and Research at the Florida Hospital Diabetes Institute, Senior Investigator at the Translational Research Institute for Metabolism and Diabetes, and an adjunct professor at the Sanford Burnham Prebys Medical Discovery Institute at Lake Nona in Orlando. Dr Pratley’s research interests include the prevention of diabetes, improving the care for older persons with diabetes, developing new drugs to treat and prevent diabetes and its complications, and understanding the role of the fat cell in increasing the risk of diabetes and heart disease. He has written several peer-reviewed articles, is a principal investigator for various trials in diabetes and obesity, and is an editorial board member and ad hoc reviewer for various journals.
  • Mark E. Molitch, MD

    Mark E. Molitch, MD

    Mark E. Molitch, MD

    Professor in Medicine-Endocrinology

    Mark Molitch, M.D. is the Martha Leland Sherwin Professor of Medicine in the Division of Endocrinology, Metabolism and Molecular Medicine at the Northwestern University Feinberg School of Medicine. Prior to coming to Northwestern in 1984, Dr. Molitch was an Associate Professor at Tufts University School of Medicine in Boston, Massachusetts. Dr. Molitch has participated in clinical research for many years, focusing on diabetic kidney disease and other long-term complications of diabetes. He has been the PI for the Northwestern center of the Diabetes Control and Complications Trial (DCCT) and its follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC) study, the Northwestern Center of the ongoing Diabetes Prevention Program Observational Study (DPPOS), the Northwestern center of the ongoing Prevention of Early Renal Loss (PERL) study in patients with type 1 diabetes, and was the Co-Principal Investigator for Northwestern center of Diabetes of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D). He has also had a long-standing interest in the pathogenesis and treatment of pituitary tumors. Dr. Molitch has been active in the American Diabetes Association (ADA). He chaired the Professional Practice Committee that wrote the 2002 ADA”Standards of Medical Care for Patients with Diabetes Mellitus,” chaired the working group that wrote the ADA Position Statement “Diabetic Nephropathy,” and served as chair of the ADA’s Provider Recognition Program. He also chaired the Technical Expert Review Panel of the National Diabetes Quality Improvement Alliance. In addition to editing eight books and journal volumes, Dr. Molitch has authored or coauthored more than 450 original papers, review articles, book chapters, case reports and other publications. In 1997, Dr. Molitch was the recipient of the “Outstanding Physician Educator in the Field of Diabetes Award” by the American Diabetes Association and in 2013 was the recipient of the “Distinguished Educator Award” of The Endocrine Society. In 2006 he was elected to the Council of The Endocrine Society. He also completed a 3 year term as Chair of the Clinical Endocrinology Update Program of the Endocrine Society in 2012 and was President of the Pituitary Society in 2012-2013.
  • Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Associate Professor of Medicine

    Dr. Abrahamson is Associate Professor of Medicine at Harvard Medical School and Medical Director at the Joslin Diabetes Center in Boston, Massachusetts. He co-directs the Joslin – Beth Israel Deaconess Medical Center (BIDMC) Diabetes-Heart Program, a joint venture between Joslin Clinic and the Division of Cardiology at BIDMC. At Beth Israel Deaconess Medical Center, Dr. Abrahamson also serves as Director of the Division of Continuing Medical Education in the Department of Medicine. At Joslin Clinic, Dr. Abrahamson is credited with reorganizing the Adult Diabetes Section into multidisciplinary teams comprised of physicians, nurse practitioners, nurse educators, nutritionists, and exercise physiologists. He is spearheading “pathways of care” for patients referred to Joslin (JoslinCare), has co-authored guidelines for both the pharmacological and perioperative management of patients with diabetes and management of hyperglycemic emergencies, and has authored more than 50 papers, review articles and chapters related to diabetes. He received his medical degree from University of Cape Town in Cape Town, South Africa, and completed his internship and residency in internal medicine and endocrinology at Groote Schuur Hospital, also in Cape Town, where he was a research fellow before joining the faculty of medicine at the University of Cape Town and Groote Schuur Hospital. Dr. Abrahamson was joint head of the endocrine unit in Cape Town before taking up a faculty appointment at Harvard Medical School and Beth Israel Hospital in 1992. Dr. Abrahamson’s research interests include evaluation of the efficacy and utility of a continuous glucose monitoring sensors in the management of patients with diabetes, and prevalence of silent coronary ischemia in patients with diabetes. Dr. Abrahamson is board certified in internal medicine and in endocrinology, diabetes and metabolism, and is a Fellow of the College of Physicians of South Africa.
  • Nuha El Sayed, MD

    Nuha El Sayed, MD

    Nuha El Sayed, MD

    Director - International Training Programs

    Nuha El Sayed, MD, is the director of International Training Programs at the Joslin Diabetes Center, associate director of the Harvard Medical Faculty Physicians’ International Initiatives, a staff physician at the Joslin Diabetes Center, and instructor in medicine at Harvard Medical School. At the Joslin Diabetes Center, Dr El Sayed oversees the education and training of international fellows, residents, medical students and visitors. She specializes in caring for overweight and obese type 2 diabetes patients, and also focuses on the use of technology in types 1 and 2 diabetes. Her research focuses on short- and long-term effects of lifestyle modification, the use of technology in diabetes and lifestyle modification, new insulin formulations and cross cultural medical care.
  • Priscilla Hollander, MD, PhD

    Priscilla Hollander, MD, PhD

    Priscilla Hollander, MD, PhD

    Endocrinologist

    Dr. Priscilla Hollander is an endocrinologist at Baylor University Medical Center in Dallas, Texas. She graduated from Harvard medical School and also has as PhD in physiology from Yale University. She is actively involved in patient care, but also participates actively in clinical research in diabetes and obesity. She has an interest in obesity with particular attention to studying new treatments for obesity both in patients with diabetes and without diabetes. She has been very active in investigating the development and role of new insulins in both type 1 and type 2 diabetes. Dr. Hollander has published extensively in both areas. Dr. Hollander is chairman of the professional advisory committee to the Texas Diabetes Council and is also diabetes champion for the Baylor hospital system and its associated physician network. She has been active in the ADA, AACE, and the Obesity Society.
  • Larry Blonde, MD

    Larry Blonde, MD

    Larry Blonde, MD

    Director, Ochsner Diabetes Clinical Research Unit

    Lawrence Blonde, MD, FACP, MACE, is Director of the Ochsner Diabetes Clinical Research Unit in the Frank Riddick Diabetes Institute, Department of Endocrinology, at the Ochsner Medical Center in New Orleans. His clinical and research activities have focused on patients with diabetes mellitus and investigations of new therapies and health care delivery systems for them. Dr Blonde is a former Chair of the Ochsner Department of Endocrinology, served as Associate Director of Graduate Medical Education, Associate Program Director of the Internal Medicine Residency, and Program Director of the Ochsner Clinic Foundation’s Endocrinology Fellowship. He is a co-author of the 2016 AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm and is presently an associate editor for Diabetes Care.
  • Anne Peters, MD, CDE

    Anne Peters, MD, CDE

    Anne Peters, MD, CDE

    Professor of Medicine

    Anne L. Peters, MD, is currently a professor at the Keck School of Medicine of the University of Southern California and the Director of the USC Clinical Diabetes Programs. She runs two diabetes centers, one in Beverly Hills and one in underserved East Los Angeles. Dr. Peters has been a principal investigator on multiple clinical trials focusing on diabetes and diabetes prevention. She has received multiple NIH and foundation grants. She has been an invited speaker at over 300 national and international medical conferences. Dr. Peters has authored three books on diabetes and over 100 articles appearing in multiple peer-reviewed medical journals. She has served on the ABIM Endocrine Board and the Board of the ADA. Dr. Peters received the ADA Outstanding Physician Clinician Award in 2008.
  • Mark Stolar, MD

    Mark Stolar, MD

    Mark Stolar, MD

    Associate Professor of Clinical Medicine

    Mark Stolar, MD, is associate professor of clinical medicine, general internal medicine, and geriatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois. Dr Stolar received his medical degree from the University of Illinois, Chicago. He completed his fellowship in Endocrinology at the Northwestern University Medical School and his residency in internal medicine at Lutheran General Hospital. Dr Stolar is board certified in endocrinology, diabetes, and metabolism, and internal medicine. Dr Stolar’s academic interests include diabetes, lipid disorders, and thyroid disease. A highly regarded speaker, he is actively involved in physician education in the area of diabetes and CV disease and has both written and presented in the US and internationally in those areas. He is currently president of the Endocrine Fellows Foundation and is actively involved in enhancing career opportunities for trainees in Endocrinology.
  • Eugene Wright, MD

    Eugene Wright, MD

    Eugene Wright, MD

    Medical Director, Primary Care and Specialty Practices

    Eugene Wright, Jr., MD, is Medical Director for Primary Care and Specialty Practices, Cape Fear Valley Health System in Fayetteville, North Carolina. He holds appointments as a consulting associate in the Department of Community and Family Medicine and the Department of Medicine of Duke University Medical Center, and as a clinical associate professor at the Campbell University School of Osteopathic Medicine (CUSOM). Dr Wright practices at The Care Clinic, a clinic for underserved and uninsured patients run by Catholic charities and local community philanthropic efforts. He has served on several advisory boards and editorial boards, was a steering committee member of the Insulin Congress, and has served on the planning committee of the Clinical Conference of the ADA since 2009.
  • Jason Gaglia, MD

    Jason Gaglia, MD

    Jason Gaglia, MD

    Assistant Professor of Medicine

    Jason Gaglia, MD, MMSc is Director of the Hood Center for Prevention of Childhood Diabetes at Joslin Diabetes Center and an Assistant Professor of Medicine at Harvard Medical School. He is a practicing adult endocrinologist at Joslin Clinic and Harvard Vanguard Medical Associates. Dr. Gaglia’s research interests include endocrine imaging and immunology of diabetes. He was previously a member of the clinical islet transplant team at the National Institute of Health. More recently he has led a team demonstrating noninvasive imaging of inflammation in the pancreas associated with the development of type 1 diabetes. Dr. Gaglia is an active member of the American Association of Clinical Endocrinologists (AACE). He is on the editorial board of Endocrine Practice, the official journal of AACE, and serves on several AACE committees.
  • Peter N. Weissman, MD, FACP, FACE

    Peter N. Weissman, MD, FACP, FACE

    Peter N. Weissman, MD, FACP, FACE

    Associate Clinical Professor of Medicine

    Peter Weissman is a board-certified specialist in internal medicine, endocrinology and metabolism. Dr. Weissman is an Associate Clinical Professor of endocrinology and internal medicine at the University of Miami Miller School of Medicine in Miami, Florida, former Adjunct Director of continuing medical education at the Joslin Diabetes Center in Boston, Massachusetts, Medical Director of the Metabolic Center for osteoporosis and diabetes complications testing and is a Clinical Endocrinologist in Miami, Florida. Dr. Weissman received his medical degree from New York University School of Medicine and completed his internship and residency at Barnes Hospital, a part of Washington University School of Medicine in St. Louis. He subsequently completed a fellowship in endocrinology at the Nation Institutes of Health (NIH) in the Human Metabolism and Endocrinology Section of the Gerontology Research Center in Baltimore, Maryland. He also completed an NIH-sponsored fellowship in endocrinology at the University of Michigan in Ann Arbor, Michigan. Active in clinical research and the principal investigator for over 250 clinical trials, Dr. Weissman’s main interests involve diabetes treatment, early detection and diagnosis of diabetes complications, integrated treatment of coexistent risk factors aimed at prevention of cardiovascular disease, and osteoporosis. Dr. Weissman is a member of several professional medical associations including the American Diabetes Association, the Endocrine Society, the American Association of Clinical Endocrinologists and the American Society for Bone and Mineral Research.

Partners

Academic

Associations